Drug: MOA-728: chronic pain clinical trials
Registry records that list "Drug: MOA-728" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
3
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
3 trials, 0 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Study Evaluating MOA-728 Oral for the Treatment of OIBD in Subjects With Chronic Non-Malignant Pain NCT00605644 | Completed | Phase 2 | Bausch Health Americas, Inc. | 2008-01 | |
| Double-Blind, Double-Dummy, 2-Period Crossover of a 20-Minute Versus a 4-hour IV of MOA-728 in Stable Methadone Subjects NCT00444158 | Completed | Phase 1 | United States | Bausch Health Americas, Inc. | 2007-03 |
| Study Evaluating Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction (OIBD) in Subjects With Chronic Non-Malignant Pain NCT00366431 | Completed | Phase 2 | United States | Bausch Health Americas, Inc. | 2006-08 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.